Heated tobacco may cut harmful chemical exposure for smokers
NCT ID NCT06179290
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adult smokers who switch to heated tobacco products have lower levels of harmful chemicals in their bodies compared to those who keep smoking regular cigarettes. Over 900 healthy smokers aged 22 to 65 took part. Researchers measured various biomarkers in urine and blood to see if switching reduces exposure to toxins.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Heated tobacco products (Ploom HTP)
What this could lead to
If successful, this could show that switching to heated tobacco products reduces exposure to harmful chemicals compared to smoking cigarettes.
What could go wrong
This is a completed study measuring biomarkers, not health outcomes. Reduced exposure does not guarantee reduced disease risk. The study was funded by a tobacco company.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispecialty Research, LLC
Lexington, Kentucky, 40509, United States
-
Alliance for Multispecialty Research, LLC
Knoxville, Tennessee, 37920, United States
-
Celerion Lincoln
Lincoln, Nebraska, 68502, United States
-
Dr. Vince Clinical Research, LLC
Overland Park, Kansas, 66212, United States
-
Pillar Clinical Research
Bentonville, Arkansas, 72712, United States
-
QPS Bio-Kinetic
Springfield, Missouri, 65802, United States
-
Spaulding Clinical Research
West Bend, Wisconsin, 53095, United States
-
Woodland Research Northwest
Rogers, Arkansas, 72758, United States